ARA (N = 61) | NO-ARA (N = 224) | p value | |
---|---|---|---|
Age | 31 (24, 40.5) | 32 (24,43) | 0.36 |
Male gender | 42 (68.9%) | 122 (54.5%) | 0.04 |
Underlying cardiac conditions | |||
RHD | 27 (45.0%) | 121 (54.3%) | 0.20 |
Mechanical prosthesis | 31 (50.8%) | 40 (17.9%) | < 0.001 |
Congenital heart disease | 11 (18.3%) | 16 (7.1%) | 0.009 |
Bicuspid aortic valve | 8 (13.1%) | 9 (4.0%) | 0.01 |
Prior IE | 8 (13.3%) | 8 (3.6%) | 0.008 |
Degenerative heart disease | 4 (6.6%) | 23 (10.4%) | 0.37 |
IV drug abuse | 0 (0%) | 7 (3.1%) | 0.35 |
Normal Heart | 1 (1.6%) | 17 (7.6%) | 0.14 |
Comorbidities | |||
DM | 6 (9.8%) | 15 (6.7%) | 0.41 |
CKD | 4 (6.6%) | 22 (9.8%) | 0.43 |
Hemodialysis | 3 (4.9%) | 8 (3.6%) | 0.70 |
Chronic steroid use | 0 (0%) | 12 (5.4%) | 0.08 |
Chronic hepatic disease | 1 (1.6%) | 10 (4.5%) | 0.47 |
Collagen vascular disease | 0 (0%) | 6 (6.7%) | 0.35 |
Clinical manifestations | |||
Duration of symptoms (Days) | 30 (14, 90) | 28 (14, 84) | 0.77 |
Temperature (Celsius) | 38 (37, 39) | 38 (37.5, 39) | 0.82 |
Heart rate (bpm) | 100 (96,120) | 100 (90,110) | 0.11 |
Laboratory data | |||
Anemia | 52 (94.5%) | 199 (93.9%) | 0.999 |
Minimum Hemoglobin (gm/dL). | 8.9 (7.5, 10) | 9.0 (7.7, 10.2) | 0.61 |
Leukocytosis | 39 (68.4%) | 137 (65.2%) | 0.65 |
TLC (*103/cc) | 13 (10.1, 17.3) | 13 (9, 18.4) | 0.96 |
Initial Creatinine (mg/dl) | 0.9 (0.7, 1.2) | 0.9 (0.7, 1.2) | 0.87 |
CRP (mg/L) | 120 (48, 183) | 77 (37, 130) | 0.03 |
Antibiotic use before referral | 67.8% | 70.5% | 0.69 |
Surgical management | 44(73.3%) | 121(66.5%) | 0.32 |